District of Columbia · Medicaid and GLP-1s

Does District of Columbia Medicaid cover Wegovy or Zepbound?

Last updated

No: District of Columbia Medicaid does not cover GLP-1s for weight loss alone.

Without Medicaid: the lowest cash prices in District of Columbia

  • Lowest compounded semaglutide in District of Columbia on a monthly plan, not FDA-approved

    Lttl

    $99/mo · first order: up to $140 off the first month

  • FD

    Lowest compounded tirzepatide in District of Columbia on a monthly plan, not FDA-approved

    Fresh Day Meds

    $125/mo

  • Next lowest per 30 days, supply stated: compounded tirzepatide in District of Columbia

    BestDaysRx

    from $145/mo · $145 per 30 days

No, not for weight loss alone: District of Columbia Medicaid is not one of the 13 programs KFF counted covering GLP-1s for obesity treatment as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Paying cash in District of Columbia, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $99/mo at Lttl and compounded tirzepatide from $125/mo at Fresh Day Meds. Compounded medicines are not FDA-approved.

Questions

District of Columbia Medicaid and GLP-1s: common questions

Does District of Columbia Medicaid cover Wegovy?

For weight loss alone, no: District of Columbia Medicaid does not cover GLP-1s for weight loss alone. Every Medicaid program must cover Wegovy for the treatment of cardiovascular disease, KFF notes, with the state's own criteria. Wegovy not covered: the cash price at your dose

Does District of Columbia Medicaid cover Zepbound?

For weight loss alone, no: District of Columbia Medicaid does not cover GLP-1s for weight loss alone. Every Medicaid program must cover Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, KFF notes, with the state's own criteria. Zepbound not covered: the cash price at your dose

Does District of Columbia Medicaid cover Ozempic or Mounjaro?

For type 2 diabetes, yes: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively." Ozempic and Mounjaro are approved for type 2 diabetes. For weight loss alone, no: District of Columbia Medicaid does not cover GLP-1s for weight loss alone.

How much do Wegovy and Zepbound alternatives cost in District of Columbia without Medicaid?

Paying cash in District of Columbia, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $99/mo at Lttl and compounded tirzepatide from $125/mo at Fresh Day Meds. Compounded medicines are not FDA-approved. Semaglutide: advertised as $99/mo at Lttl, checked Nov 11, 2026 on lttl.com. Tirzepatide: advertised as $125/mo at Fresh Day Meds, checked Nov 9, 2026 on freshdaymeds.com. Every compounded price in District of Columbia

Which states' Medicaid covers GLP-1s for weight loss?

10 programs, by KFF's January 2026 map and the states' own notices since: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. Every state's Medicaid and GLP-1s

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a Medicaid plan covers is decided by the plan and the state, and changes; ask your plan before you rely on it. This page reports the state's and KFF's published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.